Bioventix PLC (LON:BVXP) Insider Bruce Hiscock Acquires 50 Shares

Bioventix PLC (LON:BVXPGet Rating) insider Bruce Hiscock acquired 50 shares of the company’s stock in a transaction on Monday, November 21st. The stock was acquired at an average price of GBX 3,724 ($44.03) per share, for a total transaction of £1,862 ($2,201.73).

Bruce Hiscock also recently made the following trade(s):

  • On Wednesday, October 26th, Bruce Hiscock sold 204 shares of Bioventix stock. The shares were sold at an average price of GBX 3,341 ($39.51), for a total transaction of £6,815.64 ($8,059.17).

Bioventix Trading Down 1.4 %

LON BVXP opened at GBX 3,650 ($43.16) on Wednesday. The firm has a market capitalization of £190.14 million and a price-to-earnings ratio of 2,500.00. The company has a 50 day simple moving average of GBX 3,396.55 and a two-hundred day simple moving average of GBX 3,447.22.

Bioventix Increases Dividend

The company also recently announced a dividend, which was paid on Friday, November 18th. Stockholders of record on Thursday, November 3rd were issued a GBX 100 ($1.18) dividend. This is an increase from Bioventix’s previous dividend of $52.00. The ex-dividend date of this dividend was Thursday, November 3rd. This represents a dividend yield of 2.99%. Bioventix’s payout ratio is presently 8,630.14%.

Bioventix Company Profile

(Get Rating)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services.

Featured Articles

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with's FREE daily email newsletter.